New Drug Might Be Advance Against Eczema
WEDNESDAY, Dec. 14, 2022 (HealthDay News) — An experimental drug may one day be a cure for eczema, a new trial suggests. The drug, rocatinlimab, is a monoclonal antibody that researchers found prevented the recurrence of the symptoms of the skin condition for up to 20 weeks after treatment wasContinue Reading